Rideout, W.M., Coetzee, G.A., Olumi, A.F. and Jones, P.A. (1990) 5-Methylcytosine as an endogenous mutagen in human LL receptor and p53 genes. Science, 249, 1288-1290.
Montesano, R., Hainaut, P. and Wild, C.P. (1997) Hepatocellular carcinoma: From gene to public health. Journal of the National Cancer Institute, 89, 1844-1851.
Hainaut, P. and Pfeifer, G.P. (2001) Patterns of p53 G?T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis, 22, 367-374.
Fasman, G.D. (1976) Handbook of biochemistry: Section D physical chemical data. 3rd Edition, CRC Press, London and New York.
Wu, G., and Yan, S. (2002) Randomness in the primary structure of protein: methods and implications. Molecular Biology Today, 3, 55-69.
Wu, G. and Yan, S. (2006) Mutation trend of hemagglutinin of influenza A virus: A review from computational mutation viewpoint. Acta Pharmacologica Sinica, 27, 513-526.
Wu, G. and Yan, S. (2006) Fate of influenza A virus proteins. Protein and Peptide Letters, 13, 377-384.
Wu, G. and Yan, S. (2008) Lecture Notes on Computational Mutation. Nova Science Publishers, New York.
Everitt, B.S. (1999) Chance rules: An informal guide to probability, risk, and statistics. Springer, New York.
Efferth, T. (2001) The human ATP-binding cassette transporter genes: From the bench to the bedside. Current Molecular Medicine, 1, 45-65.
Pohl, A., Devaux, P.F. and Herrmann, A. (2005) Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochimica and Biophysica Acta, 1733, 29-52.
Oswald, C., Holland, I.B. and Schmitt, L. (2006) The motor domains of ABC-transporters. What can structures tell us? Naunyn-Schmiedeberg's Archives of Pharmacology, 372, 385-399.
Kim, J.H. and Kim, H.J. (2005) Childhood X-linked adrenoleukodystrophy: Clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up. Radiographics, 25, 619-631.
Shimozawa, N. (2007) Molecular and clinical aspects of peroxisomal diseases. Journal of inherited metabolic disease, 30, 193-197.
Wanders, R.J., Visser, W.F., van Roermund, S., Kemp, C.W. and Waterham, H.R. (2007) The peroxisomal ABC transporter family. Pflügers Archiv European Journal of Physiology, 453, 719-734.
Moser, H., Dubey, P. and Fatemi, A. (2004) Progress in X-linked adrenoleukodystrophy. Current opinion in neurology, 17, 263-269.
Moser, H.W., Mahmood, A. and Raymond, G.V. (2007) X-linked adrenoleukodystrophy. Nature Clinical Practice. Neurology, 3, 140-151.
Wanders, R.J. and Waterham, H.R. (2005) Peroxisomal disorders I: Biochemistry and genetics of peroxisome biogenesis disorders. Clinical Genetics, 67, 107-133.
Bezman, L., Moser, A.B., Raymond, G.V., Rinaldo, P., Watkins, P.A., Smith, K.D., Kass, N.E. and Moser, H.W. (2001) Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening. Annals of Neurol, 49, 512-517.
Elgersma, Y. and Tabak, H.F. (1996) Proteins involved in peroxisome biogenesis and functioning. Biochimica and Biophysica Acta, 1286, 269-283.
Hettema, E.H. and Tabak, H.F. (2000) Transport of fatty acids and metabolites across the peroxisomal membrane. Biochimica and Biophysica Acta, 1486, 18-27.
Clayton, P.T. (2001) Clinical consequences of defects in peroxisomal beta-oxidation. Biochemical Society Transactions, 29, 298-305.
Hargrove, J.L., Greenspan, P. and Hartle, D.K. (2004) Nutritional significance and metabolism of very long chain fatty alcohols and acids from dietary waxes. Experimental Biology and Medicine, 229, 215-226.
Kemp, S. and Wanders, R.J. (2007) X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Molecular Genetics and Metabolism, 90, 268-276.
Takano, H., Koike, R., Onodera, O. and Tsuji, S. (2000) Mutational analysis of X-linked adrenoleukodystrophy gene. Cell Biochemistry and Biophysics, 32, 177-185.
Berger, J. and G?rtner, J. (2006) X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects. Biochimica and Biophysica Acta, 1763, 1721- 1732.
Kemp, S., Pujol, A., Waterham, H.R., van Geel, B.M., Boehm, C.D., Raymond, G.V., Cutting, G.R., Wanders, R.J.A. and Moser, H.W. (2001) ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations. Human Mutation, 18, 499-515.
Bairoch, A. and Apweiler, R. (2000) The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 2000. Nucleic Acids Research, 28, 45-48.
Wu, G. (1999) The first and second order Markov chain analysis on amino acids sequence of human haemoglobin -chain and its three variants with low O2 affinity. Comparative Haematology International, 9, 148-151.
Wu, G. (2000) The first, second, third and fourth order Markov chain analysis on amino acids sequence of human dopamine-hydroxylase. Molecular Psychiatry, 5, 448-451.
Wu, G. and Yan, S.M. (2001) Prediction of presence and absence of two- and three-amino-acid sequence of human monoamine oxidase B from its amino acid composition according to the random mechanism. Biomolecular Engineering, 18, 23-27.
Wu, G. and Yan, S.M. (2002) Estimation of amino acid pairs sensitive to variants in human phenylalanine hydroxylase protein by means of a random approach. Peptides, 23, 2085-2090.
Wu, G. and Yan, S. (2003) Determination of amino acid pairs sensitive to variants in human-glucocerebrosidase by means of a random approach. Protein Engineering Design and Selection, 16, 195-199.
 Wu, G. and Yan, S. (2004) Fate of 130 hemagglutinins from different influenza A viruses. Biochemical and BioPhysical Research Communications, 317, 917-924
Wu, G. and Yan, S. (2005) Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis. Biochemical and Bio-Physical Research Communications, 326, 475-482.
Wu, G. and Yan, S. (2006) Timing of mutation in hemagglutinins from influenza A virus by means of amino-acid distribution rank and fast Fourier transform. Protein and Peptide Letters, 13, 143-148.
Wu, G. and Yan, S. (2007) Prediction of mutations in H1 neuraminidases from North America influenza A virus engineered by internal randomness. Molecular Diversity, 11, 131-140.
Wu, G. and Yan, S. (2008) Prediction of mutations engineered by randomness in H5N1 neuraminidases from influenza A virus. Amino Acids, 34, 81-90.
Yan, S. and Wu, G. (2009) Describing evolution of hemagglutinins from influenza A viruses using a differential equation. Protein and Peptide Letters, 16, 794-804.
Zhou, H.X. (2004) Improving the understanding of human genetic diseases through predictions of protein structures and protein-protein interaction sites. Current Medicinal Chemistry, 11, 539-549.
Kuvaniemi, H., Tromp, G. and Prockop, D.J. (1997) Mutations in fibrillar collagens (types I, II, III, and IV), fibril-associated collagen (type IV), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Human Mutation, 9, 300-315.
Kashtan, C.E. (2000) Alport syndromes: Phenotypic heterogeneity of progressive hereditary nephritis. Pediatric Nephrology, 14, 502-512.